Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells
Suet-Yan Kwan(The University of Texas MD Anderson Cancer Center), Kwong‐Kwok Wong(The University of Texas MD Anderson Cancer Center)
Cited by 46
Related Papers
BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
|American Journal Of Pathology|2010|220
Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
|Scientific Reports|2020|12